|
|
Home | Contact Us | Press Room | Site Overview | Help | Login | Register |
![]() |
![]() |
| About NCSL | State & Federal Issues | Legislatures | Legislative Staff | Meetings | Bookstore | Legislators & Staff Only |
| NCSL Home > State & Federal Issues: Issue Areas > Health > Forum on State Health Policy Leadership > | Add to MyNCSL |
|
|
|
State |
SAPT Block Grant Funding for Trx with Suboxone in Physician Offices |
SAPT Block Grant Funding for Trx with Suboxone in NTPs |
SAPT Block Grant Funding for Trx with NaltrexoNe in Physician Offices |
SAPT Block Grant Funding for Trx with Naltrexone in NTPs |
|
Alabama |
NO |
NO1 |
NO |
YES |
|
Alaska |
Prior authorization required |
NO |
NO |
NO |
|
Arizona |
YES2 |
YES3 |
YES4 |
YES5 |
|
Arkansas |
NO |
YES |
NO |
NO |
|
California |
NO |
NO |
NO |
NO6 |
|
Colorado |
NO |
YES |
NO |
YES |
|
Connecticut |
NO |
NO |
NO |
|
|
Delaware |
NO |
YES7 |
NO |
YES8 |
|
District of Columbia |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
|
Florida |
NO |
NO |
NO |
NO9 |
|
Georgia |
NO |
NO |
NO |
YES10 |
|
Hawaii |
NO |
NO |
NO |
NO |
|
Idaho |
NO |
NO |
NO |
NO |
|
Illinois |
NO11 |
YES12 |
NO |
YES13 |
|
Indiana |
NO |
NO |
NO |
NO |
|
Iowa |
NO |
NO14 |
NO |
NO15 |
|
Kansas |
NO |
NO |
NO |
NO |
|
Kentucky |
NO |
NO |
NO |
NO16 |
|
Louisiana |
NO |
NO |
NO |
NO |
|
Maine |
NO |
NO |
NO17 |
NO18 |
|
Maryland |
NO19 |
DK |
DK |
DK |
|
Massachusetts |
NO |
YES20 |
NO |
NO |
|
Michigan |
NO |
YES21 |
NO |
NO |
|
Minnesota |
NO |
YES22 |
NO |
YES23 |
|
Mississippi |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
|
Missouri |
NO |
NO24 |
NO |
NO25 |
|
Montana |
NO |
NO |
NO |
NO |
|
Nebraska |
NO |
NO |
NO |
NO |
|
Nevada |
NO |
NO |
NO |
NO |
|
New Hampshire |
DK |
DK |
DK |
DK |
|
New Jersey |
NO |
NO |
NO |
NO |
|
New Mexico |
NO |
NO |
NO |
NO |
|
New York |
NO |
NO26 |
NO |
NO27 |
|
North Carolina |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
|
North Dakota |
NO |
N/A |
NO |
NO28 |
|
Ohio |
NO29 |
NO30 |
NO31 |
NO32 |
|
Oklahoma |
NO |
NO |
NO |
NO |
|
Oregon |
NO |
NO |
NO |
NO |
|
Pennsylvania |
DK |
DK |
DK |
DK |
|
Rhode Island |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
NO RESPONSE |
|
South Carolina |
NO |
NO |
DK |
NO |
|
South Dakota |
NO |
NO |
NO |
NO |
|
Tennessee |
DK |
NO |
DK |
NO |
|
Texas |
DK |
YES |
YES |
DK |
|
Utah |
NO |
NO |
NO |
NO |
|
Vermont |
NO |
YES |
NO |
NO |
|
Virginia |
YES33 |
YES34 |
NO35 |
NO36 |
|
Washington |
NO |
YES37 |
NO |
NO |
|
West Virginia |
NO |
NO |
NO |
NO |
|
Wisconsin |
NO |
DK |
NO |
NO |
|
Wyoming |
NO |
NO |
NO |
NO |
1 Same guidelines as methadone treatment.
2 No limitations
3 N/A
4 N/A
5 N/A
6 SAPT Block Grant not used for naltrexone in NTPs
7 Delaware uses the SAPT BG to fund two contractual outpatient NTPs. These programs are required to follow the federal guidelines for opioid treatment programs as well as state licensing standards for outpatient NTPs.
8 All of our contracted providers are encouraged to use best practices in treating clients including use of medications. All contractors must meet state licensing standards.
9 Vivitrol is being used for alcoholism treatment using minimal block grant funds and is being done outside of traditional NTP settings. The participating providers do have separate NTPs (methadone, suboxone).
10 Naltrexone may be used by any licensed NTP at the discretion of the medical director. This includes the three public programs that receive Block Grnat funding.
11 SAPT Block Grant funding is not used to support office based practice at this time
12 As stated in response to prior questions, treatment agencies funded by DASA may utilize contract and other funds to support use of medications.
13 As stated in response to prior questions, treatment agencies funded by DASA may utilize contract and other funds to support use of medications.
14 Pay for counseling but not dosing or lab.
15 Pay for counseling but not dosing or lab.
16 Currently Block Grant funds are only provided to 2 Opiate Treatment Programs for Methadone Maintenance only.
17 Counseling may be covered if a block grant funded agency is working in a physicians office practice, but more likely that the FQHC bills using other codes than SA or block grant funds.
18 We provide funding of last resort for clients with no other payor source.
19 Will cover counseling not medication
20 Small community settings; BSAS grants
21 Must follow established federal criteria and the rules and regulations of the treatment program.
22 NTP must be enrolled in public pay system, authorized by placing county or Tribe
23 NTP must be enrolled in public pay system, authorized by placing county or Tribe
24 While being a covered item, currently NTPs are not utilizing SAPT funding for Suboxone treatment.
25 While being a covered item, currently NTPs are not utilizing SAPT funding for Suboxone treatment.
26 OASAS (Office of Alcohol and Substance Abuse Services) block grant funding is not used to fund specific medications. Block grant monies fund treatment programs
27 OASAS block grant funding is not used to fund specific medications. Block grant monies fund treatment programs.
28 No methadone clinics in ND
29 In Ohio, independently practicing physicians are not recognized as being eligible for ODADAS treatment program certification, therefore ODADAS is unable to enter into a business arrangement with them.
ODADAS-certified treatment programs can partner with physicians practicing in the same community to provide the physicians with a treatment (counseling) referral source to assist the physicians in meeting their DATA 2000 referral source requirement.
30 In Ohio, ODADAS licensed opioid agonist programs are limited to the use of only liquid methadone as the opioid agonist. Therefore, they can not administer Buprenorphine as an ODADAS treatment service.
ODADAS licensed opioid agonist programs are owned an operated by business entities which also own and operate ODADAS-certified treatment programs, in fact it is a requirement. Under this scenario, while they can not dispense the Buprenorphine, they could be partnering with community based physicians as a treatment (counseling) referral source to assist them in meeting their DATA 2000 referral source requirement.
31 In Ohio, independently practicing physicians are not recognized as being eligible for ODADAS treatment program certification, therefore ODADAS is unable to enter into a business arrangement with them.
32 In Ohio, ODADAS licensed opioid agonist programs are limited to the use of only liquid methadone as the opioid agonist. Therefore, they can not prescribe and administer Naltrexone as an ODADAS opioid agonist service.
33 If SAPT subrecipients choose. Drug is available through State-operated pharmacy
34 If SAPT subrecipients choose
35 It would be up to SAPT subrecipients, but we are not aware that naltrexone is being used.
36 It would be up to SAPT subrecipients, but we are not aware that naltrexone is being used.
37 This practice would be permissible by rule, however, we believe no more than 10 patients in NTPs have been prescribed Suboxone.
Certified and contracted programs receive an all inclusive daily rate which includes:
• medication
• physical exam
• medical exam
• counseling services
• assessment
© 2008 National Conference of State Legislatures, All Rights Reserved
Denver Office: Tel: 303-364-7700 | Fax: 303-364-7800 | 7700 East First Place | Denver, CO 80230 | Map
Washington Office: Tel: 202-624-5400 | Fax: 202-737-1069 | 444 North Capitol Street, N.W., Suite 515 | Washington, D.C. 20001